George Goldsmith, CEO at Compass Pathways, discusses show he developed a synthetic form of psilocybin, the psychoactive ingredient found in “magic mushrooms,” for use in treating depression. Goldsmith speaks with Bloomberg Businessweek anchor Carol Massar for the latest edition of Businessweek Talks.

Producer: Doni Holloway.

George Goldsmith, CEO at Compass Pathways, discusses show he developed a synthetic form of psilocybin, the psychoactive ingredient found in “magic mushrooms,” for use in treating depression. Goldsmith speaks with Bloomberg Businessweek anchor Carol Massar for the latest edition of Businessweek Talks.Producer: Doni Holloway.

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more. Watch us LIVE on YouTube: http://bit.ly/3vTiACF.

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more. Watch us LIVE on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more by harnessing the power of Bloomberg Businessweek reporters and editors.

Bloomberg Businessweek

Businessweek Talks- Compass Pathways CEO George Goldsmith

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/61f0fe48-74af-4538-9d55-ae2b004f1f68/transcript

Advertisement